We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

How To Accelerate Vaccine Production – And Avoid Speed Bumps

An illustration of a conveyor belt in a factory, with multiple vaccine vials being filled systematically
Credit: iStock

The COVID-19 pandemic put on display the various strategies available to make vaccines, some over a century old, others ramping up production for the first time.

After the SARS-CoV-2 virus was sequenced, each manufacturing route faced challenges in terms of scaling up. Some of these were unique to the pandemic situation, but racing from a lab to a finish line of full-scale production is always a bumpy ride.

This article explores key challenges in vaccine development scale up and highlights various strategies for overcoming them.

Download this article to learn more about:

  • RNA vaccines
  • Viral vectors
  • Protein subunits

Sponsored by

Access this Article for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.